SCHEMBL7324971

SCHEMBL7324971

CC(Oc1ccc(C=O)cc1)C1CNCCO1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A3 P47895 1/20 0.46
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
SLC6A2 P23975 11/20 0.40
SLC6A4 P31645 10/20 0.40
SLC6A3 Q01959 8/20 0.40
MLNR O43193 1/20 0.38
ADRB2 P07550 1/20 0.38
CHRM2 P08172 1/20 0.38
CHRM1 P11229 1/20 0.38
CHRM3 P20309 1/20 0.38
HTR2C P28335 1/20 0.38
OPRK1 P41145 1/20 0.38
KCNH2 Q12809 1/20 0.38
MEN1 O00255 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2D6 P10635 1/20 0.38
CYP2C9 P11712 1/20 0.38
MAPK1 P28482 1/20 0.38
KMT2A Q03164 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5385667 0.82 SLC6A2 (0.42) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL8104625 0.80 ALDH1A3 (0.58) ALDH1A3ALDH1A1KDM4EDRD1CYP2A6
SCHEMBL6801248 0.80 SLC6A2 (0.42) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL7819927 0.75 ALDH1A3 (0.51) ALDH1A3ALDH1A1KDM4ESLC6A2SLC6A4
SCHEMBL1662863 0.73 SSTR4 (0.41) ALDH1A1SLC6A2SLC6A4MEN1KMT2A
SCHEMBL932915 0.70 SLC6A2 (0.42) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL3188474 0.70 SLC6A2 (0.52) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL3196075 0.70 SLC6A2 (0.52) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL13745155 0.70 SLC6A2 (0.38) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3
SCHEMBL27513995 0.69 SLC6A2 (0.40) ALDH1A1KDM4ESLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5990135-A FOR TREATING A RETROVIRAL INFECTION SUCH AS HIV INFECTION; FOR EXAMPLE 5S-N-((2-PYRIDINYL)METHOXYCARBONYL)VALINYLAMINO-2-((N-3 -PYRIDINYL)METHOXYCARBONYL)AMINO-4S-HYDROXY-1,6-DIPHENYL-2-AZAHEXANE AND OTHER COMPOUNDS OF GIVEN FORMULA ABBOTT LABORATORIES (US) 1999-11-23 US disclosed
US-5631376-A PEPTIDE DERIVATIVES FOR TREATMENT OF AIDS ABBOTT LABORATORIES (US) 1997-05-20 US disclosed
US-5621109-A OXAZOLE/THIAZOLE DERIVATIVES OF HYDROXYMETHYL HYDRAZONES; SIDE EFFECT REDUCTION ABBOTT LABORATORIES (US) 1997-04-15 US disclosed
EP-0683772-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1995-11-29 EP disclosed
US-5461067-A For HIV infections ABBOTT LABORATORIES (US) 1995-10-24 US disclosed
EP-0683772-A4 RETROVIRAL PROTEASE INHIBITING COMPOUNDS. ABBOTT LAB (US) 1995-09-27 EP disclosed
WO-1994019332-A1 RETROVIRAL PROTEASE INHIBITING COMPOUNDS ABBOTT LABORATORIES (US) 1994-09-01 WO disclosed